Business Context and Reporting Period
Company: AE Biofuels, Inc. (formerly Marwich II, Ltd.)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2007
Status: Development Stage Company / Smaller Reporting Company
AE Biofuels is a developer of next-generation ethanol and biodiesel plants. The company completed a reverse merger with American Ethanol, Inc. on December 7, 2007, changing its name to AE Biofuels, Inc. As of the reporting date, the company had not commenced commercial production operations. Key assets include a 50 million gallon biodiesel facility in Kakinada, India (ready for commissioning), a cellulosic ethanol demonstration plant under construction in Butte, Montana, and multiple land sites/options in Nebraska and Illinois for future ethanol plants.
Key Financial Metrics
| Metric | 2007 | 2006 |
|---|---|---|
| Revenue | $0 | $744,450 |
| Net Loss | $(5,044,197) | $(6,069,081) |
| Operating Loss | $(14,908,503) | $(6,154,274) |
| Cash and Cash Equivalents | $720,402 | $1,213,134 |
| Marketable Securities | $2,635,892 | $0 |
| Total Assets | $33,551,076 | $17,363,793 |
| Total Liabilities | $10,022,389 | $2,066,691 |
| Stockholders' Equity | $23,528,687 | $15,297,102 |
Capital Structure: 84,557,462 shares of Common Stock outstanding; 6,487,491 shares of Series B Preferred Stock outstanding. The company has raised approximately $31.8 million to date through preferred stock sales.
Material Changes vs. Prior Period
- Revenue: Revenue dropped to $0 in 2007 compared to $744,450 in 2006. The 2006 revenue was derived from the purchase and resale of biodiesel fuel, which did not occur in 2007.
- Operating Expenses: General and Administrative expenses increased significantly to $14.65 million in 2007 from $6.16 million in 2006. This increase was driven by a $5.11 million write-off of engineering costs associated with the Sutton property and increased stock-based compensation ($1.27 million in 2007 vs. $0.36 million in 2006).
- Other Income: The company recorded significant non-operating gains in 2007, including a $9.06 million gain from the sale of a subsidiary (Wahoo Ethanol) and the dissolution of a joint venture (Sutton Ethanol), and a $544,774 gain on foreign currency exchange.
- Liquidity: Cash and cash equivalents decreased by approximately $493,000. However, the company held $2.64 million in marketable securities (short-term time deposits in India) at year-end.
Guidance, Outlook, Risks, and Contingencies
Going Concern: The company's independent auditors (BDO Seidman, LLP) have expressed substantial doubt about the company's ability to continue as a going concern due to recurring losses and negative cash flows. Management estimates current cash reserves are sufficient for only one month of domestic operating costs.
Capital Needs: The company requires significant additional debt and equity capital to construct planned ethanol plants (estimated at $240 million per plant) and complete the biodiesel facility in India. No firm commitments for this financing were identified in the filing.
Internal Controls: The company disclosed material weaknesses in internal controls over financial reporting, specifically regarding segregation of duties, revenue recognition, and accounting for stock-based compensation. Management began remediation in 2008 by hiring consultants.
Legal Proceedings:
- Logibio Albany Terminal: A complaint filed in July 2007 alleging fraud was settled in October 2007 with no payments or costs to either party.
- Dissenters' Rights: A shareholder (Cordillera Fund, LP) asserts rights to transfer Series B Preferred Stock for fair market value. The company believes it has meritorious defenses, but the outcome is uncertain.
Outlook: The company plans to begin operations of its biodiesel facility and glycerin refinery in India in 2008. It is also constructing a cellulosic ethanol demonstration plant in Montana expected to be operational in Q2 2008.
Investor Verification Checklist
- Capital Adequacy: Verify the company's ability to raise the estimated $240 million+ required per ethanol plant, given the "going concern" warning and limited cash runway.
- India Facility Status: Confirm the operational status and feedstock supply agreements for the Kakinada, India biodiesel plant, which is the primary near-term revenue source.
- Internal Control Remediation: Monitor progress on fixing material weaknesses in financial reporting to ensure future financial statements are reliable.
- Land Options: Review the status of land options in Illinois and Nebraska, noting that $445,000 in option costs were expensed in 2007 due to expiration or impairment.
- Related Party Transactions: Scrutinize the $1.7 million loan from a director (Laird Cagan) for the Energy Enzymes subsidiary and other related party fees disclosed in the notes.